Back to Search
Start Over
Ce 12 V 6 Clusters with Multi-Enzymatic Activities for Sepsis Treatment.
- Source :
-
Advanced healthcare materials [Adv Healthc Mater] 2024 Aug 11, pp. e2401581. Date of Electronic Publication: 2024 Aug 11. - Publication Year :
- 2024
- Publisher :
- Ahead of Print
-
Abstract
- Artificial enzymes, especially nanozymes, have attracted wide attention due to their controlled catalytic activity, selectivity, and stability. The rising Cerium-based nanozymes exhibit unique SOD-like activity, and Vanadium-based nanozymes always hold excellent GPx-like activity. However, most inflammatory diseases involve polymerase biocatalytic processes that require multi-enzyme activities. The nanocomposite can fulfill multi-enzymatic activity simultaneously, but large nanoparticles (>10 nm) cannot be excreted rapidly, leading to biosafety challenges. Herein, atomically precise Ce <subscript>12</subscript> V <subscript>6</subscript> clusters with a size of 2.19 nm are constructed. The Ce <subscript>12</subscript> V <subscript>6</subscript> clusters show excellent glutathione peroxidase (GPx) -like activity with a significantly lower Michaelis-Menten constant (K <subscript>m</subscript> , 0.0125 mM versus 0.03 mM of natural counterpart) and good activities mimic superoxide dismutase (SOD) and peroxidase (POD). The Ce <subscript>12</subscript> V <subscript>6</subscript> clusters exhibit the ability to scavenge the ROS including O <subscript>2</subscript> <superscript>·-</superscript> and H <subscript>2</subscript> O <subscript>2</subscript> via the cascade reactions of multi-enzymatic activities. Further, the Ce <subscript>12</subscript> V <subscript>6</subscript> clusters modulate the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β) and consequently rescue the multi-organ failure in the lipopolysaccharide (LPS)-induced sepsis mouse model. With excellent biocompatibility, the Ce <subscript>12</subscript> V <subscript>6</subscript> clusters show promise in the treatment of sepsis.<br /> (© 2024 Wiley‐VCH GmbH.)
Details
- Language :
- English
- ISSN :
- 2192-2659
- Database :
- MEDLINE
- Journal :
- Advanced healthcare materials
- Publication Type :
- Academic Journal
- Accession number :
- 39129228
- Full Text :
- https://doi.org/10.1002/adhm.202401581